ITMCTR2000003426
Recruiting
Phase 1
Study on the treatment of ulcerative colitis in mild to moderate active stage by removing dampness
Guangdong Provincial Hospital of Chinese Medicine0 sitesTBD
Conditionslcerative colitis
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- lcerative colitis
- Sponsor
- Guangdong Provincial Hospital of Chinese Medicine
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Cases that meet the diagnostic criteria of Western medicine, clinical diagnosis and TCM dampness syndrome diagnosis;
- •2\. Patients who meet the criteria of ulcerative colitis in mild and moderate active stage;
- •3\. Patients who sign informed consent and have good compliance can be followed up;
- •4\. Outpatients or inpatients aged between 18 and 70 years;
- •5\. Patients who do not use drugs or other treatments that affect the efficacy evaluation during the treatment.
Exclusion Criteria
- •1\. Chronic schistosomiasis, bacillary dysentery, intestinal tuberculosis and other infectious colitis and colon Crohn's disease, radiation enteritis and ischemic enteritis;
- •2\. Lactation, pregnant women and patients who are intolerant to the drug;
- •3\. Patients with serious primary diseases such as heart, lung, liver, kidney and hematopoietic system, and psychosis;
- •4\. Patients with serious complications such as local stenosis, toxic megacolon, intestinal obstruction, colon cancer, rectal cancer, intestinal perforation and anal disease;
- •5\. Disabled patients (dumb, deaf, blind, mental disorder, physical disability, mental disorder) as prescribed by law.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Study on Treatment of ulcerative colitis with infliximab originator and bio- Similar Targeting remissioulcerative colitisJPRN-UMIN000043098Sapporo Medical University150
Completed
Not Applicable
Improvement of treatment in ulcerative colitis, severe case and moderate case close to severe case, by early use of infliximabJPRN-UMIN000020402IBD Relapse Prevention Team50
Completed
Not Applicable
Biologica in patients with ulcerative colitis in Germany (BioColitis study)K51Ulcerative colitisDRKS00009219CED Service GmbH885
Recruiting
Not Applicable
Better control and treatment of Ulcerative Colitis (UC) by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsiesNL-OMON54471Radboud Universitair Medisch Centrum40
Completed
Not Applicable
Faecal transplant for the treatment of active ulcerative colitisACTRN12613000236796Royal Adelaide Hospital70